Related references
Note: Only part of the references are listed.Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis
Saeed Mohammad Al-Asmary et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease
Yash B. Joshi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: a meta-analysis
Shengyuan Liu et al.
SCIENTIFIC REPORTS (2015)
Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains
Douglas G. Walker et al.
EXPERIMENTAL NEUROLOGY (2013)
Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease
Fuyuki Tateno et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2012)
Mini-Mental State Examination sentence writing among community-dwelling elderly adults in Brazil: text fluency and grammar complexity
Anita Liberalesso Neri et al.
INTERNATIONAL PSYCHOGERIATRICS (2012)
Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease
Kathleen M. Shannon et al.
MOVEMENT DISORDERS (2012)
Clinical and Research Diagnostic Criteria for Alzheimer's Disease
Marie Sarazin et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2012)
SNCA polymorphisms, smoking, and sporadic Parkinson's disease in Japanese
Yoshihiro Miyake et al.
PARKINSONISM & RELATED DISORDERS (2012)
Genome-wide association study confirms extant PD risk loci among the Dutch
Javier Simon-Sanchez et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
The role of alpha-synuclein in neurotransmission and synaptic plasticity
Furong Cheng et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2011)
Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ε4 allele
Wiesje M. van der Flier et al.
LANCET NEUROLOGY (2011)
Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons
Yofre Cabeza-Arvelaiz et al.
MOLECULAR NEURODEGENERATION (2011)
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
Hong Qing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Elevated α-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease
Jan Gruendemann et al.
NUCLEIC ACIDS RESEARCH (2008)
Mechanisms of Parkinson's disease linked to pathological α-synuclein:: New targets for drug discovery
Virginia M. -Y. Lee et al.
NEURON (2006)
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients
Ornit Chiba-Falek et al.
MOVEMENT DISORDERS (2006)
Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications
M Farrer et al.
ANNALS OF NEUROLOGY (2004)
Peroxisomal proliferator-activated receptor-γ coactivator-1α (PGC-1α) enhances the thyroid hormone induction of carnitine palmitoyltransferase I (CPT-Iα)
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease
E Rockenstein et al.
BRAIN RESEARCH (2001)
Share Paper
